Dolphin Medical Services Ltd Stock Price Today (NSE: DOLPHMED)
Fundamental Score
Dolphin Medical Services Ltd Share Price — Live NSE/BSE Price, Fundamentals & Analysis
Dolphin Medical Services Ltd share price today is ₹7.52, up +0.00% on NSE/BSE as of 19 June 2026. Dolphin Medical Services Ltd (DOLPHMED) is a Small-cap company in the Healthcare Service Provider sector with a market capitalisation of ₹3.60 (Cr). The 52-week high for DOLPHMED share price is ₹7.52 and the 52-week low is ₹1.98. The company has a Return on Equity (ROE) of -0.30% and a debt-to-equity ratio of 0.08.
Dolphin Medical Services Ltd Share Price Chart — NSE/BSE Historical Performance
Dolphin Medical Services Ltd share price chart: 21.32% return over the past month. 52-week high ₹7.52, 52-week low ₹1.98.
Dolphin Medical Services Ltd — Last 10 Trading Days
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| ₹7.52 | ₹7.52 | ₹7.52 | ₹7.52 | 74.35K (Cr) | |
| ₹7.17 | ₹7.17 | ₹7.17 | ₹7.17 | 0.00 (Cr) | |
| ₹7.17 | ₹7.17 | ₹7.17 | ₹7.17 | 0.00 (Cr) | |
| ₹7.17 | ₹7.17 | ₹7.17 | ₹7.17 | 0.00 (Cr) | |
| ₹7.17 | ₹7.17 | ₹7.17 | ₹7.17 | 0.00 (Cr) | |
| ₹7.17 | ₹7.17 | ₹6.83 | ₹7.17 | 10.61L (Cr) | |
| ₹6.83 | ₹6.83 | ₹6.83 | ₹6.83 | 35.19K (Cr) | |
| ₹6.51 | ₹6.51 | ₹6.32 | ₹6.51 | 79.87K (Cr) | |
| ₹6.20 | ₹6.20 | ₹6.05 | ₹6.20 | 51.32K (Cr) | |
| ₹5.91 | ₹5.91 | ₹5.91 | ₹5.91 | 20.10K (Cr) |
Dolphin Medical Services Ltd — Last 12 Months Price History
| Month | Open | High | Low | Close | Change |
|---|---|---|---|---|---|
| ₹7.52 | ₹7.52 | ₹7.52 | ₹7.52 | +0.00% | |
| ₹6.20 | ₹7.17 | ₹6.05 | ₹7.17 | +15.65% | |
| ₹4.88 | ₹5.91 | ₹4.87 | ₹5.91 | +21.11% | |
| ₹3.83 | ₹4.88 | ₹3.64 | ₹4.88 | +27.42% | |
| ₹3.03 | ₹3.83 | ₹3.16 | ₹3.83 | +26.40% | |
| ₹2.93 | ₹3.28 | ₹2.74 | ₹3.17 | +8.19% | |
| ₹2.16 | ₹2.87 | ₹2.16 | ₹2.87 | +32.87% | |
| ₹2.04 | ₹2.27 | ₹1.99 | ₹2.27 | +11.27% | |
| ₹2.16 | ₹2.28 | ₹1.98 | ₹2.05 | -5.09% | |
| ₹2.26 | ₹2.37 | ₹2.01 | ₹2.16 | -4.42% | |
| ₹2.50 | ₹2.50 | ₹2.17 | ₹2.25 | -10.00% | |
| ₹2.29 | ₹2.53 | ₹2.20 | ₹2.39 | +4.37% |
AI Research Briefing
Powered by Gemini · 2026-04-17
Dolphin Medical is a micro-cap gamble built on hope and weak financials; avoid unless you enjoy incinerating capital.
WHAT'S HAPPENING NOW (last 2-4 weeks)
Dolphin Medical Services' share price The stock hit a new 52-week high of There was a corrigendum to the board meeting outcome held on February 12, 2026.
CORE STORY (THE REAL GAME)
This is a micro-cap stock trading on hope and fumes. The market is likely pricing in a turnaround story based on aggressive sales growth and potential for profitability, despite current negative profitability metrics.
- New 52-week high suggests speculative interest
- Reported sales growth of 33.73% over 5 years
- Recent board meeting announcements
- Significant order wins
- Turn to profitability
- Major acquisition
- Micro/SME cap equals extreme liquidity risk
- Negative ROE and ROCE
- Negative cash flow from operations
- High EV/EBITDA
- Promoter stake is relatively low at 26.44%
No FII or DII holdings. Promoter holding steady.
Indian healthcare is evolving towards technology-driven and personalized care, but Dolphin Medical's ability to capitalize on these trends is questionable.
No. Free cash flow 5Y is ₹-0.01 Cr.
The company needs to demonstrate consistent profitability and cash flow generation to justify its valuation. Without significant improvements, the stock is likely to underperform.
Primary Thesis Risk
Inability to achieve sustainable profitability will lead to a collapse in the stock price.
For educational purposes only. Not investment advice. Consult a SEBI-registered advisor before investing.
Returns & Performance
Return on Equity (ROE)
Profit generated per ₹1 of shareholder equity
Return on Capital (ROCE)
Returns generated on total capital deployed
Oper. Profit Margin (5Y Avg)
Average operating profit margin over 5 years
Dividend Yield
Annual dividend as % of current share price
Dolphin Medical Services Ltd Valuation Check
Price to Earnings (P/E)
Share price ÷ earnings per share. Lower = cheaper
Industry Avg P/E
Average P/E of all peers in this sector
Market Capitalisation
Total market value of all outstanding shares
Growth Engine
Profit Growth (Quarterly YoY)
Net profit growth vs same quarter last year
Revenue Growth (Quarterly YoY)
Revenue growth vs same quarter last year
Revenue Growth (5-Year CAGR)
Compounded annual revenue growth over 5 years
EPS Growth (5-Year CAGR)
Earnings per share growth over 5 years
Net Profit Growth (5-Year CAGR)
Compounded annual net profit growth over 5 years
Balance Sheet Health
Debt to Equity Ratio
Total debt ÷ equity. Below 0.5 = financially healthy
Interest Coverage Ratio
EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably
Free Cash Flow (5-Year Total)
Cash left after capex over 5 years. Positive = self-funded growth
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Dolphin Medical Services Ltd Fundamental Analysis & Valuation Benchmarking
Educational evaluation of DOLPHMED across key market metrics for learning purposes.
Positive Indicators
3 factors identified
Consistent Growth Track Record (34.08% CAGR)
Observation: Strong 5-year sales compound annual growth rate.
Analysis: Consistent sales CAGR >12% demonstrates sustainable growth model.
Conservative Debt Levels (D/E: 0.08)
Observation: Low leverage provides financial flexibility and reduced risk.
Analysis: Conservative debt structure offers resilience during economic downturns.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral.
Analysis: Absence of share pledging eliminates potential forced-selling pressure.
Risk Factors
8 factors identified
Below-Average Return on Equity (-0.30%)
Observation: Returns on equity are below industry benchmarks.
Analysis: ROE <10% may indicate inefficient capital utilization. Consider monitoring for operational improvements and management effectiveness.
Suboptimal ROCE (-0.18%)
Observation: Returns on capital employed are below expectations.
Analysis: ROCE <10% suggests potential inefficiencies in capital allocation.
Margin Pressure Concerns (-198.37%)
Observation: Operating margins are below industry standards.
Analysis: OPM <5% may indicate pricing pressures or cost management challenges.
Profit Decline Concern (-50.00%)
Observation: Significant year-over-year profit contraction observed.
Analysis: Declining profitability requires investigation into underlying causes.
Revenue Contraction (-28.00%)
Observation: Sales decline may indicate market challenges or competitive pressures.
Analysis: Negative revenue growth requires analysis of market conditions.
Negative Free Cash Flow (₹-0.01 Cr over 5Y)
Observation: Cash outflows exceed inflows.
Analysis: Negative FCF requires analysis of capital expenditure cycle.
Low Promoter Commitment (26.44%)
Observation: Reduced promoter stake may indicate limited confidence.
Analysis: Low promoter holding may raise questions about management commitment.
No Dividend Distribution
Observation: Company does not currently pay dividends to shareholders.
Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints.
Dolphin Medical Services Ltd vs Healthcare Service Provider Peers
Peer Comparison - Healthcare Service Provider
Compare Dolphin Medical Services Ltd with 10 other companies in the same sector
| Company Info | Fundamental | Valuation | Profitability | Financial Health | Growth | Dividend | ||||
|---|---|---|---|---|---|---|---|---|---|---|
Company Company name | Score Bull Run comprehensive fundamental score based on 20+ metrics | Price Current trading price of the stock | Market Cap Total value of all shares in the market | P/E Price per share divided by earnings per share | ROE Net income divided by shareholder equity | ROCE Earnings before interest and tax divided by capital employed | Debt/Eq Total debt divided by total equity | Profit 5Y Average annual profit growth over 5 years | Sales 5Y Average annual sales growth over 5 years | Dividend Annual dividend per share divided by price per share |
Dolphin Medical Services LtdDolphin Medical...Selected✓ DOLPHMED • 526504 | 16.4/100 | ₹7.52₹8 | ₹3.60₹3.60 | — — | -0.30%Poor -0.30% Poor | -0.18%Poor -0.18% Poor | 0.08Excellent 0.1 Excellent | 13.97%Good 13.97% Good | 34.08%Excellent 34.08% Excellent | 0.00% |
Dr Lal PathLabs LtdDr Lal PathLabs... LALPATHLAB • 539524 | 64.3/100 | ₹1617.20₹1617 | ₹25557.40₹25557.40 | 47.83Average 47.8 Average | 24.30%Excellent 24.30% Excellent | 28.88%Excellent 28.88% Excellent | 0.07Excellent 0.1 Excellent | 16.69%Excellent 16.69% Excellent | 13.09%Good 13.09% Good | 0.79% |
Vijaya Diagnostic Centre LtdVijaya Diagnost... VIJAYA • 543350 | 53.7/100 | ₹1261.40₹1261 | ₹10272.45₹10272.45 | 67.39Average 67.4 Average | 19.00%Good 19.00% Good | 20.91%Excellent 20.91% Excellent | 0.42Excellent 0.4 Excellent | 18.97%Excellent 18.97% Excellent | 15.00%Excellent 15.00% Excellent | 0.20% |
Metropolis Healthcare LtdMetropolis Heal... METROPOLIS • 542650 | 48.9/100 | ₹536.15₹536 | ₹10124.28₹10124.28 | 63.98Average 64.0 Average | 11.53%Average 11.53% Average | 14.66%Average 14.66% Average | 0.14Excellent 0.1 Excellent | -0.56%Poor -0.56% Poor | 9.22%Good 9.22% Good | 0.20% |
Thyrocare Technologies LtdThyrocare Techn... THYROCARE • 539871 | 40.5/100 | ₹512.15₹512 | ₹7724.80₹7724.80 | 60.48Average 60.5 Average | 16.15%Good 16.15% Good | 24.78%Excellent 24.78% Excellent | 0.05Excellent 0.1 Excellent | -0.64%Poor -0.64% Poor | 9.62%Good 9.62% Good | 1.44% |
Krsnaa Diagnostics LtdKrsnaa Diagnost... KRSNAA • 543328 | 39.6/100 | ₹538.45₹538 | ₹2626.09₹2626.09 | 30.73Average 30.7 Average | 9.29%Poor 9.29% Poor | 12.52%Average 12.52% Average | 0.30Excellent 0.3 Excellent | 22.05%Excellent 22.05% Excellent | 21.41%Excellent 21.41% Excellent | 0.34% |
Suraksha Diagnostic LtdSuraksha Diagno... SURAKSHA • 544293 | 47.1/100 | ₹289.60₹290 | ₹1534.08₹1534.08 | 48.05Average 48.0 Average | 16.46%Good 16.46% Good | 17.84%Good 17.84% Good | 0.51Good 0.5 Good | 16.38%Excellent 16.38% Excellent | 9.86%Good 9.86% Good | 0.00% |
3B Blackbio Diagnostics Ltd3B Blackbio Dia... 3BBLACKBIO • 532067 | 66.1/100 | ₹1225.40₹1225 | ₹1080.56₹1080.56 | 22.01Average 22.0 Average | 19.40%Good 19.40% Good | 25.75%Excellent 25.75% Excellent | 0.00Excellent 0.0 Excellent | 44.03%Excellent 44.03% Excellent | 27.29%Excellent 27.29% Excellent | 0.32% |
One Global Service Provider IncOne Global Serv... ONEGLOBAL • 514330 | 69.5/100 | ₹424.15₹424 | ₹1070.08₹1070.08 | 24.39Average 24.4 Average | 42.31%Excellent 42.31% Excellent | 56.38%Excellent 56.38% Excellent | 0.00Excellent 0.0 Excellent | 128.82%Excellent 128.82% Excellent | — — | 0.00% |
Sastasundar Ventures LtdSastasundar Ven... SASTASUNDR • 533259 | 40.3/100 | ₹313.95₹314 | ₹1042.27₹1042.27 | — — | 4.63%Poor 4.63% Poor | -1.33%Poor -1.33% Poor | 0.01Excellent 0.0 Excellent | 23.31%Excellent 23.31% Excellent | 24.47%Excellent 24.47% Excellent | 0.00% |
46.5/100 | ₹233.90₹234 | ₹826.72₹826.72 | 30.47Average 30.5 Average | 27.08%Excellent 27.08% Excellent | 28.85%Excellent 28.85% Excellent | 0.48Excellent 0.5 Excellent | — — | — — | 0.00% | |
Top Healthcare Service Provider Stocks
View all →By Bull Run Score
By Return on Equity
By Market Cap
- Dr Lal PathLabs Ltd share price25557.40 Cr
- Vijaya Diagnostic Centre Ltd share price10272.45 Cr
- Metropolis Healthcare Ltd share price10124.28 Cr
- Thyrocare Technologies Ltd share price7724.80 Cr
- Krsnaa Diagnostics Ltd share price2626.09 Cr
Dolphin Medical Services Ltd Quarterly Performance
Latest quarterly metrics for DOLPHMED — revenue growth and profit growth vs same quarter last year
Revenue Growth (YoY)
-28.00%
Latest quarter vs same quarter previous year
Net Profit Growth (YoY)
-50.00%
Latest quarter net profit vs same quarter previous year
5-Year Revenue CAGR
34.08%
Compounded annual revenue growth over 5 years
5-Year Profit CAGR
13.97%
Compounded annual net profit growth over 5 years
Dolphin Medical Services Ltd Technical Indicators
SMA 50, SMA 200, RSI and volume signals for DOLPHMED — calculated from daily price history
Momentum is strong — price may be stretched. Watch for pullbacks.
Technical indicators are for educational purposes only. Not investment advice.
Dolphin Medical Services Ltd Financial Statements
Annual income statement, balance sheet and cash flow for Dolphin Medical Services Ltd (DOLPHMED) — sourced from NSE/BSE filings.
Loading Financial Statements...
Fetching financial data for Dolphin Medical Services Ltd
About DOLPHMED (Dolphin Medical Services Ltd)
Dolphin Medical Services Ltd is a prominent healthcare provider committed to delivering comprehensive and advanced medical solutions within the region. With a focus on patient-cent...ric care, DOLPHMED offers a wide spectrum of diagnostic services, including cutting-edge imaging technologies, laboratory testing, and specialized health screenings. We pride ourselves on employing a team of highly qualified and experienced medical professionals who are dedicated to accuracy, efficiency, and personalized attention for every individual. DOLPHMED aims to be a trusted partner in promoting health and well-being within the community by continuously investing in innovative technologies and upholding the highest standards of quality and ethics in the healthcare industry. At Dolphin Medical Services Ltd, we understand the critical role of timely and accurate diagnoses in ensuring positive patient outcomes. Therefore, we are dedicated to providing state-of-the-art diagnostic facilities equipped with the latest medical equipment. Our team of skilled technicians and radiologists work in tandem to deliver precise and detailed results, enabling doctors to make informed decisions about treatment plans. Furthermore, DOLPHMED emphasizes a comfortable and supportive environment for patients undergoing various diagnostic procedures, ensuring their comfort and minimizing anxiety. We are committed to maintaining confidentiality and adhering to strict protocols to safeguard patient information. DOLPHMED is deeply rooted in its commitment to the local community, striving to be a valuable resource for individuals seeking accessible and reliable healthcare services. Through collaborations with local hospitals, clinics, and healthcare professionals, we aim to expand our reach and improve access to essential diagnostic services. We actively participate in health awareness programs and initiatives, promoting preventive care and empowering individuals to take control of their health. Dolphin Medical Services Ltd aspires to be a pillar of support in the community, fostering a healthier and more vibrant society by delivering superior healthcare solutions with compassion and integrity.
Company Details
Key Leadership
DOLPHMED Share Price: Frequently Asked Questions
What is the current share price of Dolphin Medical Services Ltd?
Dolphin Medical Services Ltd (DOLPHMED) trades at ₹7.52 on NSE and BSE. Market cap ₹3.60 (Cr). Educational data only.
What is the P/E ratio of Dolphin Medical Services Ltd?
Dolphin Medical Services Ltd has a P/E of N/Ax vs industry average 39.28x.
What is the Bull Run score for Dolphin Medical Services Ltd?
Dolphin Medical Services Ltd has a Bull Run score of 16.4/100 based on 25+ financial parameters.
Does Dolphin Medical Services Ltd pay dividends?
Dolphin Medical Services Ltd has a dividend yield of 0.00%. Past dividends don't guarantee future payments.
What is the ROE of Dolphin Medical Services Ltd?
Dolphin Medical Services Ltd has ROE of -0.30%. Higher ROE indicates better use of shareholder equity.
What is the debt-to-equity ratio of Dolphin Medical Services Ltd?
Dolphin Medical Services Ltd has debt-to-equity of 0.08.
Is Dolphin Medical Services Ltd a good investment?
Bull Run gives Dolphin Medical Services Ltd a score of 16.4/100. This is not investment advice — consult a SEBI-registered advisor.